Outcome of transsphenoidal surgery for acromegaly using strict criteria for surgical cure

Clinical Endocrinology

Volumn 45, Issue 4, 1996, Pages 407-413

  Sheaves, R ^a   Jenkins, P ^a   Blackburn, P ^a   Huneidi, A H ^a   Afshar, F ^a   Medbak, S ^a   Grossman, A B ^a   Besser, G M ^a   Wass, J A H ^a,b  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b RADCLIFFE INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOTROPIN; ESTRADIOL; FOLLITROPIN; GLUCAGON; GROWTH HORMONE; INSULIN; LUTEINIZING HORMONE; TESTOSTERONE; THYROTROPIN;

ACROMEGALY; ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; HYPOPHYSIS ADENOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TRANSSPHENOIDAL SURGERY; TREATMENT OUTCOME;

EID: 0029826419     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2265.1996.8370847.x     Document Type: Article

References (33)

1. Alexander, L., Appleton, D., Hall, R., Ross, W.M. & Wilkinson, R. (1980) Epidemiology of acromegaly in the Newcastle region. Clinical Endocrinology, 12, 71-79.
2. Arafah, B.M., Rosenzweig, J.L., Fenstermaker, R., Salazar, R., McBride, C.E. & Selman, W. (1987) Value of growth hormone dynamics and somatomedin C (insulin like growth factor 1) levels in predicting the long term benefit after transsphenoidal surgery for acromegaly. Journal of Laboratory Clinical Medicine, 109, 346-354.
3. Barkan, A.L. (1989) Acromegaly; diagnosis and therapy. Endocrinology and Metabolism Clinics of North America, 18, 277-310.
4. Barkan, A.L., Beitius, I.Z. & Kelch, R.P. (1988) Plasma insulin-like growth factor-1/somatomedin C in acromegaly: correlation with the degree of growth hormone hypersecretion. Journal of Clinical Endocrinology and Metabolism, 67, 69-73.
5. Barreca, A., Ciccarelli, E., Minuto, F., Bruzzi, P., Giordano, G. & Camanni, F. (1989). Insulin-like growth factor-1 and daily growth hormone profile in the assessment of active acromegaly. Acta Endocrinologica, 120, 629-635.
6. Bates, A.S., Van't Hoff, W., Jones, J.M. & Clayton, R.N. (1993). An audit of outcome of treatment in acromegaly. Quarterly Journal of Medicine, 86, 293-299.
7. Cushing, H. (1909) Partial hypophysectomy for acromegaly. Annals of Surgery, 50, 1002-1017.
8. Dashe, A.M., Gamm, R.E., Crist, C.A., Habener, J.F. & Solomon, D.H. (1963) A water deprivation test for the differential diagnosis of polyuria. Journal of the American Medical Association, 185, 699-703.
9. Dorashian, R.D., O'Halloran, D.J., Hunt, A., Beardwell, C.G. & Shalet, S.M. (1993). Relationships between insulin-like growth factor-1 levels and growth hormone concentrations during diurnal profiles and following oral glucose in acromegaly. Clinical Endocrinology, 38, 589-593.
10. Fahlbusch, R., Honegger, J. and Buchfelder, M. (1992). Surgical Management of Acromegaly. Endocrinology and Metabolism Clinics of North America, 21, 669-691.
11. Fahlbusch, R., Honegger, J., Schott, W. and Buschfelder, M. 1994. Results of Surgery in acromegaly. In Treating Acromegaly (ed. J.A.H. Wass), pp. 49-54. Journal of Endocrinology Ltd, Bristol.
12. Grisoli, F., Leclercq, T., Jaquet, P., Guibout, M., Winteler, J.P., Hassoun, J. & Vincentelli, F. (1985). Transsphenoidal surgery for acromegaly. Long-term results in 100 patients. Surgical Neurology, 23, 513-519.
13. Hardy, J. & Somma, M. (1979). Acromegaly: surgical treatment by transsphenoidal microsurgical removal of the pituitary adenoma. In Clinical Management of Pituitary Disorders (eds G.T. Tindall & W.F. Collins). pp. 209-217. Raven Press, New York.
14. Jenkins, D., O'Brien, I., Johnson, A., Shakespear, R., Sheppard, M.C., & Stewart, P.M. (1995) The Birmingham pituitary database: auditing the outcome of the treatment of acromegaly. Clinical Endocrinology, 43, 517-522.
15. Kendall-Taylor, P., Osman, I.A., James, R.A. Chatterjee, S. & Mathias, D.B. (1994). Outcome of surgery for acromegaly. In Treating Acromegaly (ed. J.A.H. Wass), pp. 65-68. Journal of Endocrinology Ltd. Bristol.
16. Lamberts, S.W.J. (1992) Acromegaly. In Clinical Endocrinology (ed A. Grossman), pp. 154-168. Blackwell Scientific Publications.
17. Laws, E.R. Jr. (1982) Complications of transsphenoidal microsurgery for pituitary adenoma. In Modern Neurosurgery (ed. M. Brook), p. 181. Berlin, Springer-Verlag.
18. Laws, E.R. (1994) Results of transsphenoidal microsurgical management of acromegaly. In Treating Acromegaly (ed. J.A.H. Wass), pp. 59-63. Journal of Endocrinology Ltd. Bristol.
19. Losa, M., Oeckler, R. Schopohl, J., Muller, O.A., Alba-Lopez, J. & Von Werder, K. (1989) Evaluation of selective transsphenoidal adenomectomy by endocrinological testing and somatomedin C measurement in acromegaly. Journal of Neurosurgery, 70, 561-567.
20. McLellan, A.R., Connell, J.M.C., Beastall, G.H., Teasdale, G. & Davies, D.L. (1988) Growth hormone, body composition and somatomedin C after treatment of acromegaly. Quarterly Journal of Medicine, 260, 997-1008.
21. Markussis, V., Beshyah, S.A., Fisher, C., Sharp, P., Micolaides, A.N. & Johnston, D.G. (1992) Detection of premature atherosclerosis by high-resolution ultrasonography in symptom free hypopituitary adults. Lancet 340, 1188-1192.
22. Melmed, S. (1990) Acromegaly. New England Journal for Medicine, 322, 966-977.
23. Osman, I.A., James, R.A., Chatterjee, S., Mathias, D. & Kendall-Taylor, P. (1994) Factors determining the long-term outcome of surgery for acromegaly. Quarterly Journal of Medicine, 87, 617-623.
24. Ritchie, C.M., Atkinson, A.B., Kennedy, A.L., Lyons, A.R., Gordon, D.S., Fannin, T. & Hadden, D.R. (1990). Ascertainment and natural history of treated acromegaly in Northern Ireland. Ulster Medical Journal, 59, 52-62.
25. Roelfsema, F., Van Dulken, H. & Froelich, M. (1985). Long-term results of transsphenoidal pituitary microsurgery in 60 acromegalic patients. Clinical Endocrinology, 23, 555-565.
26. Ross, D.A. & Wilson, C.B. (1988). Results of transsphenoidal microsurgery for growth hormone-secreting pituitary adenoma in a series of 214 patients. Journal of Neurosurgery, 68, 854-867.
27. Scanlon, M.F. (1994) Dopamine agonists in the treatment of acromegaly. In Treating Acromegaly (ed. J.A.H. Wass), pp. 139-145. Journal of Endocrinology Ltd. Bristol.
28. Sheaves, R. (1993) Interpretation of IGF-I levels in the assessment of acromegaly. The Royal Society of Medicine Current Medical Literature Series: Growth Hormone and Growth Factors 8, 59-61.
29. Sheaves, R. (1994) Pituitary irradiation for acromegaly. In Treating Acromegaly. (ed. J.A.H. Wass), pp. 103-108. Journal of Endocrinology Ltd. Bristol.
30. Sheppard, M.C. (1994) Aims of treatment and definition of cure. In Treating Acromegaly (ed. J.A.H. Wass), pp. 17-30. Journal of Endocrinology Ltd. Bristol.
31. Wass, J.A.H. (1993) Acromegaly: treatment after 100 years. British Medical Journal, 307, 1505-1506.
32. Wass, J.A.H. (1994) Treatment of acromegaly with octreotide (ed. J.A.H. Wass), pp. 151-163. Journal of Endocrinology Ltd., Bristol.
33. Wright, A.D., Hill, D.M., Lowy, C. & Fraser, R.T. (1970) Mortality in acromegaly. Quarterly Journal of Medicine, 39, 1-16.